Deciphering the emerging role of SUMO conjugation in the hypoxia-signaling cascade

Biological Chemistry

Volumn 394, Issue 4, 2013, Pages 459-469

  Nüñez O'Mara, Analía ^a   Berra, Edurne ^a  

^a CIC BIOGUNE   (Spain)

Author keywords

Cancer; Hypoxia inducible factor (HIF); Hypoxic pathway; Oxygen homeostasis; Prolyl hydroxylase domain containing proteins (PHDs); SUMOylation

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

BINDING SITE; CANCER CELL; CELL HYPOXIA; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONJUGATION; ENVIRONMENTAL STRESS; GLUCOSE TRANSPORT; GLYCOLYSIS; HISTONE UBIQUITINATION; HUMAN; HYDROXYLATION; METABOLIC STRESS; NONHUMAN; OXIDATIVE STRESS; POLYMERIZATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSACTIVATION;

ANIMALS; ANOXIA; HUMANS; PROCOLLAGEN-PROLINE DIOXYGENASE; SIGNAL TRANSDUCTION; SUMOYLATION;

EID: 84878542447     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0319     Document Type: Review

References (110)

1. Agbor, T.A., Cheong, A., Comerford, K.M., Scholz, C.C., Bruning, U., Clarke, A., Cummins, E.P., Cagney, G., and Taylor, C.T. (2011). Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia. J. Biol. Chem. 286, 4718-4726.
2. Anckar, J., Hietakangas, V., Denessiouk, K., Thiele, D.J., Johnson, M.S., and Sistonen, L. (2006). Inhibition of DNA binding by differential sumoylation of heat shock factors. Mol. Cell. Biol. 26, 955-964.
3. Bae, S.H., Jeong, J.W., Park, J.A., Kim, S.H., Bae, M.K., Choi, S.J., and Kim, K.W. (2004). Sumoylation increases HIF-1α stability and its transcriptional activity. Biochem. Biophys. Res. Comm. 324, 394-400.
4. Bailey, D. and O'Hare, P. (2004). Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279, 692-703.
5. Bayer, P., Arndt, A., Metzger, S., Mahajan, R., Melchior, F., Jaenicke, R., and Becker, J. (1998). Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280, 275-286.
6. Berta, M.A., Mazure, N., Hattab, M., Pouyssegur, J., and Brahimi-Horn, M.C. (2007). SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity. Biochem. Biophys. Res. Comm. 360, 646-652.
7. Bhaskar, V., Valentine, S.A., and Courey, A.J. (2000). A functional interaction between dorsal and components of the Smt3 conjugation machinery. J. Biol. Chem. 275, 4033-4040.
8. Bohren, K.M., Nadkarni, V., Song, J.H., Gabbay, K.H., and Owerbach, D. (2004). A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279, 27233-27238.
9. Bossis, G., Malnou, C.E., Farras, R., Andermarcher, E., Hipskind, R., Rodriguez, M., Schmidt, D., Muller, S., Jariel-Encontre, I., and Piechaczyk, M. (2005). Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964-6979.
10. Branzei, D., Sollier, J., Liberi, G., Zhao, X., Maeda, D., Seki, M., Enomoto, T., Ohta, K., and Foiani, M. (2006). Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks. Cell 127, 509-522.
11. Cai, Q. and Robertson, E.S. (2010). Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PloS One 5, e12636.
12. Cai, Q., Verma, S.C., Kumar, P., Ma, M., and Robertson, E.S. (2010). Hypoxia inactivates the VHL tumor suppressor through PIASymediated SUMO modification. PloS One 5, e9720.
13. Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., Holsboer, F., and Arzt, E. (2007). RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 131, 309-323.
14. Chen, A., Mannen, H., and Li, S.S. (1998). Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/ pseudogenes. Biochem. Mol. Biol. Int. 46, 1161-1174.
15. Cheng, J., Bawa, T., Lee, P., Gong, L., and Yeh, E.T. (2006). Role of desumoylation in the development of prostate cancer. Neoplasia 8, 667-676.
16. Cheng, J., Kang, X., Zhang, S., and Yeh, E.T. (2007). SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia. Cell 131, 584-595.
17. Chiu, S.Y., Asai, N., Costantini, F., and Hsu, W. (2008). SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol. 6, e310.
18. Choudhury, B.K. and Li, S.S. (1997). Identification and characterization of the SMT3 cDNA and gene from nematode Caenorhabditis elegans. Biochem. Biophys. Res. Comm. 234, 788-791.
19. Chupreta, S., Holmstrom, S., Subramanian, L., and Iniguez- Lluhi, J.A. (2005). A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties. Mol. Cell. Biol. 25, 4272-4282.
20. Cimarosti, H., Lindberg, C., Bomholt, S.F., Ronn, L.C., and Henley, J.M. (2008). Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology 54, 280-289.
21. Comerford, K.M., Leonard, M.O., Karhausen, J., Carey, R., Colgan, S.P., and Taylor, C.T. (2003). Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc. Natl. Acad. Sci. USA 100, 986-991.
22. Cremona, C.A., Sarangi, P., Yang, Y., Hang, L.E., Rahman, S., and Zhao, X. (2012). Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol Cell 45, 422-432.
23. Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., and Rocha, S. (2010). Mechanism of hypoxia-induced NF-κB. Mol. Cell. Biol. 30, 4901-4921.
24. Dadke, S., Cotteret, S., Yip, S.C., Jaffer, Z.M., Haj, F., Ivanov, A., Rauscher, F. 3rd, Shuai, K., Ng, T., Neel, B.G., et al. (2007). Regulation of protein tyrosine phosphatase 1B by sumoylation. Nat. Cell Biol. 9, 80-85.
25. Datwyler, A.L., Lattig-Tunnemann, G., Yang, W., Paschen, W., Lee, S.L., Dirnagl, U., Endres, M., and Harms, C. (2011). SUMO2/3 conjugation is an endogenous neuroprotective mechanism. J. Cereb. Blood Flow Metab. 31, 2152-2159.
26. Desterro, J.M., Thomson, J., and Hay, R.T. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297-300.
27. Desterro, J.M., Rodriguez, M.S., and Hay, R.T. (1998). SUMO-1 modification of I κBα inhibits NF-κB activation. Mol. Cell 2, 233-239.
28. Desterro, J.M., Rodriguez, M.S., Kemp, G.D., and Hay, R.T. (1999). Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10618-10624.
29. Deyrieux, A.F., Rosas-Acosta, G., Ozbun, M.A., and Wilson, V.G. (2007). Sumoylation dynamics during keratinocyte differentiation. J. Cell Sci. 120, 125-136.
30. Di Bacco, A., Ouyang, J., Lee, H.Y., Catic, A., Ploegh, H., and Gill, G. (2006). The SUMO-specific protease SENP5 is required for cell division. Mol. Cell. Biol. 26, 4489-4498.
31. Dou, H., Huang, C., Singh, M., Carpenter, P.B., and Yeh, E.T. (2010). Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol. Cell 39, 333-345.
32. Eladad, S., Ye, T.Z., Hu, P., Leversha, M., Beresten, S., Matunis, M.J., and Ellis, N.A. (2005). Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification. Hum. Mol. Genet. 14, 1351-1365.
33. Figueroa-Romero, C., Iniguez-Lluhi, J.A., Stadler, J., Chang, C.R., Arnoult, D., Keller, P.J., Hong, Y., Blackstone, C., and Feldman, E.L. (2009). SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J. 23, 3917-3927.
34. Frerichs, K.U. and Hallenbeck, J.M. (1998). Hibernation in ground squirrels induces state and species-specific tolerance to hypoxia and aglycemia: an in vitro study in hippocampal slices. J. Cereb. Blood Flow Metab. 18, 168-175.
35. Frerichs, K.U., Kennedy, C., Sokoloff, L., and Hallenbeck, J.M. (1994). Local cerebral blood flow during hibernation, a model of natural tolerance to " cerebral ischemia". J. Cereb. Blood Flow Metab. 14, 193-205.
36. Frerichs, K.U., Smith, C.B., Brenner, M., DeGracia, D.J., Krause, G.S., Marrone, L., Dever, T.E., and Hallenbeck, J.M. (1998). Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc. Natl. Acad. Sci. USA 95, 14511-14516.
37. Giorgino, F., de Robertis, O., Laviola, L., Montrone, C., Perrini, S., McCowen, K.C., and Smith, R.J. (2000). The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 97, 1125-1130.
38. Girdwood, D., Bumpass, D., Vaughan, O.A., Thain, A., Anderson, L.A., Snowden, A.W., Garcia-Wilson, E., Perkins, N.D., and Hay, R.T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054.
39. Golebiowski, F., Matic, I., Tatham, M.H., Cole, C., Yin, Y., Nakamura, A., Cox, J., Barton, G.J., Mann, M., and Hay, R.T. (2009). System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2, ra24.
40. Gong, L. and Yeh, E.T. (2006). Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869-15877.
41. Gong, L., Millas, S., Maul, G.G., and Yeh, E.T. (2000). Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355-3359.
42. Hanania, U., Furman-Matarasso, N., Ron, M., and Avni, A. (1999). Isolation of a novel SUMO protein from tomato that suppresses EIX-induced cell death. Plant J. 19, 533-541.
43. Hang, J. and Dasso, M. (2002). Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277, 19961-19966.
44. Heaton, P.R., Santos, A., Rosas-Acosta, G., and Wilson, V.G. (2012). Analysis of global sumoylation changes occurring during keratinocyte differentiation. PloS One 7, e30165.
45. Hecker, C.M., Rabiller, M., Haglund, K., Bayer, P., and Dikic, I. (2006). Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281, 16117-16127.
46. Huang, C., Han, Y., Wang, Y., Sun, X., Yan, S., Yeh, E.T., Chen, Y., Cang, H., Li, H., Shi, G., et al. (2009). SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 28, 2748-2762.
47. Johnson, E.S. and Blobel, G. (1997). Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799-26802.
48. Johnson, E.S., Schwienhorst, I., Dohmen, R.J., and Blobel, G. (1997). The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16, 5509-5519.
49. Kagey, M.H., Melhuish, T.A., and Wotton, D. (2003). The polycomb protein Pc2 is a SUMO E3. Cell 113, 127-137.
50. Kahyo, T., Nishida, T., and Yasuda, H. (2001). Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713-718.
51. Kang, X., Li, J., Zou, Y., Yi, J., Zhang, H., Cao, M., Yeh, E.T., and Cheng, J. (2010). PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia. Oncogene 29, 5568-5578.
52. Kim, K.I., Baek, S.H., Jeon, Y.J., Nishimori, S., Suzuki, T., Uchida, S., Shimbara, N., Saitoh, H., Tanaka, K., and Chung, C.H. (2000). A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275, 14102-14106.
53. Knipscheer, P., Flotho, A., Klug, H., Olsen, J.V., van Dijk, W.J., Fish, A., Johnson, E.S., Mann, M., Sixma, T.K., and Pichler, A. (2008). Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 31, 371-382.
54. Kotaja, N., Karvonen, U., Janne, O.A., and Palvimo, J.J. (2002). PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222-5234.
55. Kuo, H.Y., Chang, C.C., Jeng, J.C., Hu, H.M., Lin, D.Y., Maul, G.G., Kwok, R.P., and Shih, H.M. (2005). SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl. Acad. Sci. USA 102, 16973-16978.
56. Kurepa, J., Walker, J.M., Smalle, J., Gosink, M.M., Davis, S.J., Durham, T.L., Sung, D.Y., and Vierstra, R.D. (2003). The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem. 278, 6862-6872.
57. Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., and de The, H. (2008). Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10, 547-555.
58. Lapenta, V., Chiurazzi, P., van der Spek, P., Pizzuti, A., Hanaoka, F., and Brahe, C. (1997). SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics 40, 362-366.
59. Lee, B. and Muller, M.T. (2009). SUMOylation enhances DNA methyltransferase 1 activity. Biochem. J. 421, 449-461.
60. Lee, Y.J., Miyake, S., Wakita, H., McMullen, D.C., Azuma, Y., Auh, S., and Hallenbeck, J.M. (2007). Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J. Cereb. Blood Flow Metab. 27, 950-962.
61. Lee, Y.J., Castri, P., Bembry, J., Maric, D., Auh, S., and Hallenbeck, J.M. (2009). SUMOylation participates in induction of ischemic tolerance. J. Neurochem. 109, 257-267.
62. Li, S.J. and Hochstrasser, M. (1999). A new protease required for cell-cycle progression in yeast. Nature 398, 246-251.
63. Lima, C.D. and Reverter, D. (2008). Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J. Biol. Chem. 283, 32045-32055.
64. Lin, D.Y., Huang, Y.S., Jeng, J.C., Kuo, H.Y., Chang, C.C., Chao, T.T., Ho, C.C., Chen, Y.C., Lin, T.P., Fang, H.I., et al. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354.
65. Lois, L.M. and Lima, C.D. (2005). Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J. 24, 439-451.
66. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107.
67. Manza, L.L., Codreanu, S.G., Stamer, S.L., Smith, D.L., Wells, K.S., Roberts, R.L., and Liebler, D.C. (2004). Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17, 1706-1715.
68. Matic, I., van Hagen, M., Schimmel, J., Macek, B., Ogg, S.C., Tatham, M.H., Hay, R.T., Lamond, A.I., Mann, M., and Vertegaal, A.C. (2008). In vivo identification of human small ubiquitinlike modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell Proteomics 7, 132-144.
69. Matunis, M.J., Coutavas, E., and Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell. Biol. 135, 1457-1470.
70. Messner, S., Schuermann, D., Altmeyer, M., Kassner, I., Schmidt, D., Schar, P., Muller, S., and Hottiger, M.O. (2009). Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J. 23, 3978-3989.
71. Mikolajczyk, J., Drag, M., Bekes, M., Cao, J.T., Ronai, Z., and Salvesen, G.S. (2007). Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J. Biol. Chem. 282, 26217-26224.
72. Mo, Y.Y., Yu, Y., Theodosiou, E., Ee, P.L., and Beck, W.T. (2005). A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683.
73. Mooney, S.M., Grande, J.P., Salisbury, J.L., and Janknecht, R. (2010). Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49, 1-10.
74. Mukhopadhyay, D., Ayaydin, F., Kolli, N., Tan, S.H., Anan, T., Kametaka, A., Azuma, Y., Wilkinson, K.D., and Dasso, M. (2006). SUSP1 antagonizes formation of highly SUMO2/3- conjugated species. J. Cell. Biol. 174, 939-949.
75. Mullen, J.R., Chen, C.F., and Brill, S.J. (2010). Wss1 is a SUMO-dependent isopeptidase that interacts genetically with the Slx5-Slx8 SUMO-targeted ubiquitin ligase. Mol. Cell. Biol. 30, 3737-3748.
76. Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen- Tannoudji, M., Babinet, C., Pandolfi, P.P., and Dejean, A. (2005). The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779.
77. Nishida, T., Tanaka, H., and Yasuda, H. (2000). A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267, 6423-6427.
78. Nishida, T., Kaneko, F., Kitagawa, M., and Yasuda, H. (2001). Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J. Biol. Chem. 276, 39060-39066.
79. Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N., and Yasuda, H. (1999). In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Comm. 254, 693-698.
80. Pichler, A., Gast, A., Seeler, J.S., Dejean, A., and Melchior, F. (2002). The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120.
81. Pichler, A., Knipscheer, P., Oberhofer, E., van Dijk, W.J., Korner, R., Olsen, J.V., Jentsch, S., Melchior, F., and Sixma, T.K. (2005). SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 12, 264-269.
82. Potts, P.R. and Yu, H. (2005). Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol. Cell. Biol. 25, 7021-7032.
83. Poukka, H., Karvonen, U., Janne, O.A., and Palvimo, J.J. (2000). Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97, 14145-14150.
84. Rodriguez, M.S., Dargemont, C., and Hay, R.T. (2001). SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659.
85. Sachdev, S., Bruhn, L., Sieber, H., Pichler, A., Melchior, F., and Grosschedl, R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088-3103.
86. Sacher, M., Pfander, B., Hoege, C., and Jentsch, S. (2006). Control of Rad52 recombination activity by double-strand break-induced SUMO modification. Nat. Cell Biol. 8, 1284-1290.
87. Saitoh, H. and Hinchey, J. (2000). Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258.
88. Schmidt, D. and Muller, S. (2002). Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99, 2872-2877.
89. Schulz, S., Chachami, G., Kozaczkiewicz, L., Winter, U., Stankovic- Valentin, N., Haas, P., Hofmann, K., Urlaub, H., Ovaa, H., Wittbrodt, J., et al. (2012). Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 13, 930-938.
90. Shao, R., Zhang, F.P., Tian, F., Anders Friberg, P., Wang, X., Sjoland, H., and Billig, H. (2004). Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1α in adult mouse brain and heart in vivo. FEBS Lett. 569, 293-300.
91. Shen, L.N., Dong, C., Liu, H., Naismith, J.H., and Hay, R.T. (2006). The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem. J. 397, 279-288.
92. Shen, L.N., Geoffroy, M.C., Jaffray, E.G., and Hay, R.T. (2009). Characterization of SENP7, a SUMO-2/3-specific isopeptidase. Biochem. J. 421, 223-230.
93. Shin, E.J., Shin, H.M., Nam, E., Kim, W.S., Kim, J.H., Oh, B.H., and Yun, Y. (2012). DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep. 13, 339-346.
94. Song, J., Durrin, L.K., Wilkinson, T.A., Krontiris, T.G., and Chen, Y. (2004). Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101, 14373-14378.
95. Song, J., Zhang, Z., Hu, W., and Chen, Y. (2005). Small ubiquitinlike modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J. Biol. Chem. 280, 40122-40129.
96. Takahashi, Y., Kahyo, T., Toh, E.A., Yasuda, H., and Kikuchi, Y. (2001). Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276, 48973-48977.
97. Tatham, M.H., Jaffray, E., Vaughan, O.A., Desterro, J.M., Botting, C.H., Naismith, J.H., and Hay, R.T. (2001). Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374.
98. Tojo, M., Matsuzaki, K., Minami, T., Honda, Y., Yasuda, H., Chiba, T., Saya, H., Fujii-Kuriyama, Y., and Nakao, M. (2002). The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system. J. Biol. Chem. 277, 46576-46585.
99. van Hagen, M., Overmeer, R.M., Abolvardi, S.S., and Vertegaal, A.C. (2010). RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated hypoxia-inducible factor-2α . Nucleic Acids Res. 38, 1922-1931.
100. Wang, L. and Banerjee, S. (2004). Differential PIAS3 expression in human malignancy. Oncol. Rep. 11, 1319-1324.
101. Weger, S., Hammer, E., and Heilbronn, R. (2005). Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett. 579, 5007-5012.
102. Xu, Z. and Au, S.W. (2005). Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1. Biochem. J. 386, 325-330.
103. Xu, Y., Zuo, Y., Zhang, H., Kang, X., Yue, F., Yi, Z., Liu, M., Yeh, E.T., Chen, G., and Cheng, J. (2010). Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J. Biol. Chem. 285, 36682-36688.
104. Yang, W., Sheng, H., Warner, D.S., and Paschen, W. (2008a). Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation. J. Cereb. Blood Flow Metab. 28, 892-896.
105. Yang, W., Sheng, H., Warner, D.S., and Paschen, W. (2008b). Transient global cerebral ischemia induces a massive increase in protein sumoylation. J. Cereb. Blood Flow Metab. 28, 269-279.
106. Yang, W., Thompson, J.W., Wang, Z., Wang, L., Sheng, H., Foster, M.W., Moseley, M.A., and Paschen, W. (2012). Analysis of oxygen/glucose-deprivation- induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. J. Proteome Res. 11, 1108-1117.
107. Yurchenko, V., Xue, Z., and Sadofsky, M.J. (2006). SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol. Cell. Biol. 26, 1786-1794.
108. Zhang, H., Saitoh, H., and Matunis, M.J. (2002). Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22, 6498-6508.
109. Zhang, F.P., Mikkonen, L., Toppari, J., Palvimo, J.J., Thesleff, I., and Janne, O.A. (2008). Sumo-1 function is dispensable in normal mouse development. Mol. Cell. Biol. 28, 5381-5390.
110. Zhao, X. and Blobel, G. (2005). A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl. Acad. Sci. USA 102, 4777-4782.